Get started
Work

Abstract PS3-11-05: Trastuzumab Combined with Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-Pathological Complete Response HER2-Positive Early Breast Cancer Following Neoadjuvant Therapy: A Multicenter Phase II Study

Year: 2026
Type: conference-abstract
DOI: 10.1158/1557-3265.sabcs25-ps3-11-05
Authors: C. Wang, F. Fu, J. Zhang, S. Lin, Z. Song, Z. Ouyang, X. Chen, M. Lin, G. Cui, G. Han, W. Guo, X. Chen, L. Jia, C. Song, S. Yang, R. Luo, Y. Yan, Y. Zeng, D. Chen, J. Lin, F. Yang, R. Huang, Y. Wang, Z. Zeng, Z. Zhang
Institutions: Fujian Medical University, Union Hospital, Hebei Medical University, Fourth Hospital of Hebei Medical University, Xiamen University, First Affiliated Hospital of Xiamen University, First Affiliated Hospital of Fujian Medical University, Fujian Provincial Cancer Hospital, Fujian Provincial Hospital, Cangzhou Central Hospital, Shanxi Provincial Cancer Hospital, Xingtai People's Hospital, Zhongshan Hospital of Xiamen University, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Second Affiliated Hospital of Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7129436887
Cites:
Cited by:
Related to: